91 related articles for article (PubMed ID: 1309227)
1. Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity.
Bunn PA; Chan D; Dienhart DG; Tolley R; Tagawa M; Jewett PB
Cancer Res; 1992 Jan; 52(1):24-31. PubMed ID: 1309227
[TBL] [Abstract][Full Text] [Related]
2. Effects of neuropeptides on human lung and breast cancer cells.
Bunn PA; Dienhart DG; Chan D; Tagawa M; Jewett P
J Natl Cancer Inst Monogr; 1992; (13):145-51. PubMed ID: 1389687
[TBL] [Abstract][Full Text] [Related]
3. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
4. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
5. Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin.
Sethi T; Rozengurt E
Cancer Res; 1991 Jul; 51(13):3621-3. PubMed ID: 1711414
[TBL] [Abstract][Full Text] [Related]
6. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo.
Sethi T; Langdon S; Smyth J; Rozengurt E
Cancer Res; 1992 May; 52(9 Suppl):2737s-2742s. PubMed ID: 1314136
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo.
Bunn PA; Helfrich BA; Brenner DG; Chan DC; Dykes DJ; Cohen AJ; Miller YE
Clin Cancer Res; 1998 Nov; 4(11):2849-58. PubMed ID: 9829752
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of calcium mobilization but not proliferation by bombesin and tachykinin neuropeptides in human small cell lung cancer cells.
Takuwa N; Takuwa Y; Ohue Y; Mukai H; Endoh K; Yamashita K; Kumada M; Munekata E
Cancer Res; 1990 Jan; 50(2):240-4. PubMed ID: 1688510
[TBL] [Abstract][Full Text] [Related]
9. Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides.
Gudermann T; Roelle S
Endocr Relat Cancer; 2006 Dec; 13(4):1069-84. PubMed ID: 17158754
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
Lee YS; Nishio K; Ogasawara H; Funayama Y; Ohira T; Saijo N
Cancer Res; 1995 Mar; 55(5):1075-9. PubMed ID: 7866991
[TBL] [Abstract][Full Text] [Related]
11. A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro.
Woll PJ; Rozengurt E
Cancer Res; 1990 Jul; 50(13):3968-73. PubMed ID: 1693879
[TBL] [Abstract][Full Text] [Related]
12. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
13. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
Kado-Fong H; Malfroy B
J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
[TBL] [Abstract][Full Text] [Related]
14. Multiple neuropeptides mobilise calcium in small cell lung cancer: effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin.
Woll PJ; Rozengurt E
Biochem Biophys Res Commun; 1989 Oct; 164(1):66-73. PubMed ID: 2478133
[TBL] [Abstract][Full Text] [Related]
15. [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism.
MacKinnon AC; Armstrong RA; Waters CM; Cummings J; Smyth JF; Haslett C; Sethi T
Br J Cancer; 1999 Jun; 80(7):1026-34. PubMed ID: 10362111
[TBL] [Abstract][Full Text] [Related]
16. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.
Langdon S; Sethi T; Ritchie A; Muir M; Smyth J; Rozengurt E
Cancer Res; 1992 Aug; 52(16):4554-7. PubMed ID: 1379515
[TBL] [Abstract][Full Text] [Related]
17. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
Moody TW; Staley J; Zia F; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611
[TBL] [Abstract][Full Text] [Related]
18. Gastrin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer cells.
Sethi T; Rozengurt E
Cancer Res; 1992 Nov; 52(21):6031-5. PubMed ID: 1327522
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
[TBL] [Abstract][Full Text] [Related]
20. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth.
Beekman A; Helfrich B; Bunn PA; Heasley LE
Cancer Res; 1998 Mar; 58(5):910-3. PubMed ID: 9500449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
